+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes



Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes



British Journal of Cancer 84(6): 813-818



Transgenic mouse models were established to study tumorigenesis of bronchiolo-alveolar adenocarcinomas derived from alveolar type II pneumocytes (AT-II cells). Transgenic lines expressing the murine oncogene c- myc under the control of the lung-specific surfactant protein C promoter developed multifocal bronchiolo-alveolar hyperplasias, adenomas and carcinomas respectively, whereas transgenic lines expressing a secretable form of the epidermal growth factor (IgEGF), a structural and functional homologue of transforming growth factor alpha (TGF alpha), developed hyperplasias of the alveolar epithelium. Since the oncogenes c- myc and TGF alpha are frequently overexpressed in human lung bronchiolo-alveolar adenocarcinomas, these mouse lines are useful as models for human lung bronchiolo-alveolar adenocarcinomas. The average life expectancies of hemizygous and homozygous c- myc transgenics were 14.25 months and 9.2 months, respectively, suggesting that a dosage effect of c- myc caused an accelerated bronchiolo-alveolar adenocarcinoma formation. First analyses of double transgenics, hemizygous for both c- myc and IgEGF, show that these mice develop bronchiolo-alveolar adenocarcinomas at the average age of 9 months, indicating that these oncogenes cooperate during the lung cancer formation. Our results demonstrate that c- myc and EGF are directly involved and cooperate with one another during formation of bronchiolo-alveolar adenocarcinomas in the lung.

(PDF emailed within 0-6 h: $19.90)

Accession: 010450561

Download citation: RISBibTeXText

PMID: 11259097

DOI: 10.1054/bjoc.2000.1676


Related references

Increased susceptibility to the tobacco carcinogen 4- -1- -1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells. Journal of Cancer Research & Clinical Oncology 129(2): 71-75, February, 2003

Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells. Journal of Cancer Research and Clinical Oncology 129(2): 71-75, 2003

Pulmonary fibrosis in transgenic mice over-expressing TNF-alpha in alveolar type II pneumocytes. European Cytokine Network 5(2): 181, 1994

Distribution of transforming growth factor-beta and its receptor in bronchiolo-alveolar cell hyperplasia and bronchiolo-alveolar carcinoma. Hunan Yi Ke Da Xue Xue Bao 23(4): 345-348, 2001

Epidermal growth factor receptor-linked activation of extracellular signal-regulated protein kinase pathways in asbestos-exposed alveolar type II pneumocytes. FASEB Journal 15(5): A945, March 8, 2001

Lipid analysis of broncho alveolar lavage fluids in a patient with bronchiolo alveolar cell carcinoma a comparative study with pulmonary alveolar proteinosis. Japanese Journal of Chest Diseases 41(8): 742-748, 1982

Epidermal growth factor up-regulates the amiloride-sensitive Na+ conductance of cultured adult rat alveolar pneumocytes. Journal of Physiology (Cambridge) 505P: 65P-66P, 1997

Therapeutic management of extensive bronchiolo-alveolar adenocarcinoma: chemotherapy or inhibitors of epidermal growth factor receptor tyrosine kinase?. Revue de Pneumologie Clinique 63(3): 147-154, 2007

Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. American Journal of Physiology. Lung Cellular and Molecular Physiology 285(5): L1046-L1054, 2003

Identification and isolation of an alveolar macrophage derived growth factor for type ii pneumocytes. Journal of Cell Biology 107(6 PART 3): 268A, 1988

Stimulated rabbit alveolar macrophages secrete a growth factor for type II pneumocytes. American Journal of Respiratory Cell and Molecular Biology 1(2): 101-109, 1989

Expression of ovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice. Endocrine 8(3): 251-259, 1998

Bronchiolo-alveolar hyperplasia Progenitor of bronchiolo-alveolar carcinoma in a sheep. Indian Journal of Animal Sciences 66(9): 904-906, 1996

Regulation of alveolar type ii cell differentiation in fetal rhesus monkeys comparison of the effects of epidermal growth factor and cortisol on surfactant apoprotein a production and epidermal growth factor receptor expression. American Review of Respiratory Disease 143(4 PART 2): A520, 1991